Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Jan Lycke

Professor, adjungerad

Jan Lycke
Professor, adjungerad
jan.lycke@gu.se
+46 31-342 9047
0733-109149

Postal Address: Gröna stråket 11, plan 3, 41345 Göteborg
Visiting Address: Neurosjukvården, Gröna stråket 11, plan 3, SU/Sahlgrenska sjukhuset , 41345 Göteborg


Department of Clinical Neuroscience at Institute of Neuroscience and Physiology (More Information)
Box 430
405 30 Göteborg
Visiting Address: Blå stråket 7, plan 3, Sahlgrenska , 413 45 Göteborg

Latest publications

Infection Risks among Patients with Multiple Sclerosis Treated with Fingolimod, Natalizumab, Rituximab, and Injectable Therapies
G. Luna, P. Alping, J. Burman, K. Fink, A. Fogdell-Hahn et al.
JAMA Neurology, Journal article 2020
Journal article

Cerebrospinal fluid growth-associated protein 43 in multiple sclerosis.
Åsa P Sandelius, Sofia Sandgren, Markus Axelsson, Clas Malmeström, Lenka Novakova et al.
Scientific reports, Journal article 2019
Journal article

Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis.
Claire Bridel, Wessel N van Wieringen, Henrik Zetterberg, Betty M Tijms, Charlotte E Teunissen et al.
JAMA neurology, Journal article 2019
Journal article

Efficacy of alemtuzumab over 6 years in relapsing-remitting multiple sclerosis patients who relapsed between courses 1 and 2: Post hoc analysis of the CARE-MS studies
B. Van Wijmeersch, B. A. Singer, A. Boster, S. Broadley, O. Fernandez et al.
Multiple Sclerosis Journal, Journal article 2019
Journal article

Natalizumab, rituximab and fingolimod as escalation therapy in multiple sclerosis
M. Boremalm, A. Juto, Markus Axelsson, Lenka Novakova, T. Frisell et al.
European Journal of Neurology, Journal article 2019
Journal article

Cerebrospinal fluid NCAM levels are modulated by disease-modifying therapies
Markus Axelsson, N. Dubuisson, Lenka Novakova, Clas Malmeström, G. Giovannoni et al.
Acta Neurologica Scandinavica, Journal article 2019
Journal article

Showing 41 - 50 of 73

2014

2013

MS risk genes are transcriptionally regulated in CSF leukocytes at relapse
Margareta Jernås, Clas Malmeström, Markus Axelsson, Caroline Olsson, Intawat Nookaew et al.
Multiple sclerosis (Houndmills, Basingstoke, England), Journal article 2013
Journal article

The impact of rituximab therapy in multiple sclerosis on cerebrospinal fluid cell gene expression
Margareta Jernås, Clas Malmeström, Intawat Nookaew, Hans Wadenvik, Bob Olsson et al.
Multiple Sclerosis Journal: 29th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis / 18th Annual Conference of Rehabilitation in MS, Conference contribution 2013
Conference contribution

Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis.
Ashley H Beecham, Nikolaos A Patsopoulos, Dionysia K Xifara, Mary F Davis, Anu Kemppinen et al.
Nature genetics, Journal article 2013
Journal article

Clinical case reviews in multiple sclerosis spasticity: experiences from around Europe.
Jürgen Koehler, Maria P Amato, Celia Oreja-Guevara, Jan Lycke
Expert review of neurotherapeutics, Review article 2013
Review article

Neurofilament light and heavy subunits compared as therapeutic biomarkers in multiple sclerosis
J Kuhle, Clas Malmeström, Markus Axelsson, K Plattner, O Yaldizli et al.
Acta neurologica Scandinavica, Journal article 2013
Journal article

Serum levels of LIGHT in MS
Clas Malmeström, Alan Gillett, Margareta Jernås, Mohsen Khademi, Markus Axelsson et al.
Multiple sclerosis (Houndmills, Basingstoke, England), Journal article 2013
Journal article

Showing 41 - 50 of 73

Page Manager: Katinka Almrén|Last update: 9/1/2015
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?

Denna text är utskriven från följande webbsida:
http://neurophys.gu.se/english/departments/clinical_neuroscience_and_rehabilitation/about-us/staff/?publicationPageNumber=5&selectedTab=2&languageId=100001&disableRedirect=true&returnUrl=http%3A%2F%2Fneurophys.gu.se%2Fsektioner%2Fklinisk-neurovetenskap%2Fom-sektionen%2Fpersonal%2F%3FpublicationPageNumber%3D2%26selectedTab%3D2%26languageId%3D100000%26print%3Dtrue%26userId%3Dxlycja&userId=xlycja
Utskriftsdatum: 2020-04-04